Drug Trial Radar · NCT01366820
Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC
Last checked: Nov 19, 2026Latest source record: Feb 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
261
Actual
Start
Feb 2013
Primary completion
Jan 2016
Study completion Jan 2016
Sponsor
- Lead sponsor
- Neuren Pharmaceuticals LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jun 6, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 16 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether NNZ-2566 is safe and effective in the treatment of Traumatic Brain Injury (TBI).
Conditions
- Brain Injuries
Interventions
NNZ-2566Drug
Solution for intravenous infusion. Intravenous bolus infusion over 10 minutes followed by a continuous intravenous maintenance infusion for a total of 72 consecutive hours.
PlaceboDrug
Sodium Chloride 0.9% Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduced incidence, compared to placebo, of adverse events (AEs) and serious adverse events (SAEs)Time frame: AEs to discharged or Day 30 post randomization, whichever occurs first, and SAEs through to 3 months (defined as 12-14 weeks), post randomization.
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Arrowhead Regional Medical Center
Colton, California
University of California, Davis Medical Center
Sacramento, California
The Queen's Medical Center
Honolulu, Hawaii
Detroit Receiving Hospital and University Health Center
Detroit, Michigan
Sinai Grace Hospital
Detroit, Michigan
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.